No Data
Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Alkermes Raised to Buy by Stifel on Increased Confidence for ALKS2680
Glaukos Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $221 Price Target
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday